Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold

• Váldodahkkit: Costanza Ceni (Dahkki), Michael J. Benko (Dahkki), Kawthar A. Mohamed (Dahkki), Giulio Poli (Dahkki), Miriana Di Stefano (Dahkki), Tiziano Tuccinardi (Dahkki), Maria Digiacomo (Dahkki), Massimo Valoti (Dahkki), Robert B. Laprairie (Dahkki), Marco Macchia (Dahkki), Simone Bertini (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

A growing body of evidence underlines the crucial role of GPR55 in physiological and pathological conditions. In fact, GPR55 has recently emerged as a therapeutic target for several diseases, including cancer and neurodegenerative and metabolic disorders. Several lines of evidence highlight GPR55�...